Literature DB >> 11256607

Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang.

E Samper1, F A Goytisolo, P Slijepcevic, P P van Buul, M A Blasco.   

Abstract

Ku86 together with Ku70, DNA-PKcs, XRCC4 and DNA ligase IV forms a complex involved in repairing DNA double-strand breaks (DSB) in mammals. Yeast Ku has an essential role at the telomere; in particular, Ku deficiency leads to telomere shortening, loss of telomere clustering, loss of telomeric silencing and deregulation of the telomeric G-overhang. In mammals, Ku proteins associate to telomeric repeats; however, the possible role of Ku in regulating telomere length has not yet been addressed. We have measured telomere length in different cell types from wild-type and Ku86-deficient mice. In contrast to yeast, Ku86 deficiency does not result in telomere shortening or deregulation of the G-strand overhang. Interestingly, Ku86-/- cells show telomeric fusions with long telomeres (>81 kb) at the fusion point. These results indicate that mammalian Ku86 plays a fundamental role at the telomere by preventing telomeric fusions independently of the length of TTAGGG repeats and the integrity of the G-strand overhang.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11256607      PMCID: PMC1083725          DOI: 10.1093/embo-reports/kvd051

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  38 in total

1.  Ku binds telomeric DNA in vitro.

Authors:  A Bianchi; T de Lange
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

2.  Telomeres and telomerase.

Authors:  M A Blasco; S M Gasser; J Lingner
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

Review 3.  Telomerase and cancer: revisiting the telomere hypothesis.

Authors:  C Autexier; C W Greider
Journal:  Trends Biochem Sci       Date:  1996-10       Impact factor: 13.807

4.  Yeast Ku as a regulator of chromosomal DNA end structure.

Authors:  S Gravel; M Larrivée; P Labrecque; R J Wellinger
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

5.  Disease states associated with telomerase deficiency appear earlier in mice with short telomeres.

Authors:  E Herrera; E Samper; J Martín-Caballero; J M Flores; H W Lee; M A Blasco
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

6.  MEC1-dependent redistribution of the Sir3 silencing protein from telomeres to DNA double-strand breaks.

Authors:  K D Mills; D A Sinclair; L Guarente
Journal:  Cell       Date:  1999-05-28       Impact factor: 41.582

7.  Elongated telomeres in scid mice.

Authors:  P Hande; P Slijepcevic; A Silver; S Bouffler; P van Buul; P Bryant; P Lansdorp
Journal:  Genomics       Date:  1999-03-01       Impact factor: 5.736

8.  Requirement for Ku80 in growth and immunoglobulin V(D)J recombination.

Authors:  A Nussenzweig; C Chen; V da Costa Soares; M Sanchez; K Sokol; M C Nussenzweig; G C Li
Journal:  Nature       Date:  1996-08-08       Impact factor: 49.962

9.  Mutation of yeast Ku genes disrupts the subnuclear organization of telomeres.

Authors:  T Laroche; S G Martin; M Gotta; H C Gorham; F E Pryde; E J Louis; S M Gasser
Journal:  Curr Biol       Date:  1998-05-21       Impact factor: 10.834

10.  The yeast Ku heterodimer is essential for protection of the telomere against nucleolytic and recombinational activities.

Authors:  R M Polotnianka; J Li; A J Lustig
Journal:  Curr Biol       Date:  1998-07-02       Impact factor: 10.834

View more
  115 in total

1.  Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres.

Authors:  E Samper; J M Flores; M A Blasco
Journal:  EMBO Rep       Date:  2001-08-23       Impact factor: 8.807

2.  Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2.

Authors:  Katia Ancelin; Michele Brunori; Serge Bauwens; Catherine-Elaine Koering; Christine Brun; Michelle Ricoul; Jean-Patrick Pommier; Laure Sabatier; Eric Gilson
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 3.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

Review 4.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

5.  Effects of double-strand break repair proteins on vertebrate telomere structure.

Authors:  Chao Wei; Rose Skopp; Minoru Takata; Shunichi Takeda; Carolyn M Price
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

6.  EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70Delta mutants.

Authors:  Laura Maringele; David Lydall
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

7.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells.

Authors:  Susan M Bailey; Mark A Brenneman; Edwin H Goodwin
Journal:  Nucleic Acids Res       Date:  2004-07-16       Impact factor: 16.971

9.  Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends.

Authors:  Anne E Stellwagen; Zara W Haimberger; Joshua R Veatch; Daniel E Gottschling
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

10.  Increased p53 activity does not accelerate telomere-driven ageing.

Authors:  Isabel García-Cao; Marta García-Cao; Antonia Tomás-Loba; Juan Martín-Caballero; Juana M Flores; Peter Klatt; María A Blasco; Manuel Serrano
Journal:  EMBO Rep       Date:  2006-03-31       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.